The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive RevenuesSummaryGBI Research has released its research - 'The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues'. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until 2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.ScopeThe scope of this report includes: - Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016 - Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases. - Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan - Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage patterns - Key drivers and barriers that have a significant impact on the market - Coverage of pipeline molecules in various phases of drug development - Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck & Co, Inc. - Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to - Align product portfolio to the markets with high growth potential - Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth - Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety - Develop key strategic initiatives by understanding key focus areas of leading companies - Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Future of Dermatology Therapeutics, Analysis and Market
Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues
Published on March 2010
Report Summary
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues
Summary
GBI Research has released its research - 'The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 -
Increasing Prescription Rate to Drive Revenues'. The report provides in-depth analysis of unmet needs, drivers and barriers that
impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top
five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until
2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the
leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report
is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI
Research's team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases.
- Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany,
France, Italy, Spain, and Japan
- Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage
patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche,
GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck &
Co, Inc.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics
market
Reasons to buy
The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets
poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and
better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 1/11

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps
Table of Content
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 10
2 Global Dermatology Therapeutics Market: Scope of Research 12
2.1 Introduction 12
2.2 GBI Research Report Guidance 12
3 Global Dermatology Therapeutics Market: Market Characterization 13
3.1 Market Forecasts 13
3.2 Usage Patterns 14
3.2.1 Diseased Population 14
3.2.2 Treatment Seeking Population 15
3.2.3 Diagnosis Population 16
3.2.4 Prescription Population 17
3.2.5 Therapy Usage Patterns 18
3.2.6 Geographical Distribution 19
4 Global Dermatology Therapeutics Market: US Market 20
4.1 Market Overview 20
4.2 Market Forecasts 20
4.3 Usage Patterns 21
4.3.1 Diseased Population 21
4.3.2 Treatment Seeking Population 22
4.3.3 Diagnosis Population 23
4.3.4 Prescription Population 24
4.3.5 Therapy Usage Patterns 25
5 Global Dermatology Therapeutics Market: European Market 27
5.1 Market Overview 27
5.2 Market Forecasts 27
5.3 Usage Patterns 28
5.3.1 Diseased Population 28
5.3.2 Treatment Seeking Population 29
5.3.3 Diagnosis Population 30
5.3.4 Prescription Population 31
5.3.5 Therapy Usage Patterns 32
6 Global Dermatology Therapeutics Market : Japan Market 34
6.1 Market Overview 34
6.2 Market Forecasts 34
6.3 Usage Patterns 35
6.3.1 Diseased Population 35
6.3.2 Treatment Seeking Population 36
6.3.3 Diagnosis Population 37
6.3.4 Prescription Population 38
6.3.5 Therapy Usage Patterns 39
7 Global Psoriasis Therapeutics Market 41
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 2/11

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
7.1 Market Overview 41
7.2 Market Forecasts 42
7.3 Average Cost of Therapy 43
7.4 Usage Patterns 44
7.4.1 Diseased Population 44
7.4.2 Treatment Seeking Population 45
7.4.3 Diagnosis Population 46
7.4.4 Prescription Population 47
7.4.5 Therapy Usage Patterns 48
7.5 Product Analysis 50
7.5.1 Enbrel (etanercept) 50
7.5.2 Humira (adalimumab) 50
7.5.3 Amevive (alefacept) 51
7.5.4 Remicade (infliximab) 51
7.5.5 Stelara (ustekinumab, CNTO1275) 51
7.5.6 Clobex (clobetasol propionate) 51
7.5.7 Tazorac (tazarotene, Avage) 51
7.5.8 Dovonex (calcipotriene) 52
7.5.9 Neoral (cyclosporine) 52
7.6 Drug Pipeline Analysis 52
7.6.1 Psoriasis Therapeutics ' Phase III Clinical Pipeline 53
7.6.2 Psoriasis Therapeutics ' Phase II Clinical Pipeline 54
8 Global Atopic Dermatitis Therapeutics Market 57
8.1 Market Overview 57
8.2 Market Forecasts 57
8.3 Average Cost of Therapy 59
8.4 Usage Patterns 60
8.4.1 Diseased Population 60
8.4.2 Treatment Seeking Population 61
8.4.3 Diagnosis Population 62
8.4.4 Prescription Population 63
8.4.5 Therapy Usage Patterns 64
8.5 Product Analysis 65
8.5.1 Protopic (Tacrolimus) 65
8.5.2 Elidel (Pimecrolimus) 66
8.5.3 MimyX 66
8.5.4 Atopiclair 66
8.5.5 Topical Corticosteroids 66
8.6 Drug Pipeline Analysis 66
9 Global Acne Therapeutics Market 71
9.1 Market Overview 71
9.2 Market Forecasts 71
9.3 Usage Patterns 73
9.3.1 Diseased Population 73
9.3.2 Treatment Seeking Population 74
9.3.3 Diagnosis Population 75
9.3.4 Prescription Population 76
9.3.5 Therapy Usage Patterns 77
9.4 Product Analysis 78
9.5 Drug Pipeline Analysis 78
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 3/11

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
10 Global Rosacea Disease Therapeutics Market 84
10.1 Market Overview 84
10.2 Market Forecasts 84
10.3 Average Cost of Therapy 85
10.4 Usage Patterns 86
10.4.1 Diseased Population 86
10.4.2 Treatment Seeking Population 87
10.4.3 Diagnosis Population 88
10.4.4 Prescription Population 89
10.4.5 Therapy Usage Patterns 90
10.5 Product Analysis 91
10.6 Drug Pipeline Analysis 92
11 Global Dermatology Therapeutics Market: Market Drivers and Restraints 95
11.1 Market Drivers 95
11.1.1 Steady Increase in the Elderly Population 95
11.1.2 Stable Increase in Incidence Rates for Dermatology Diseases 96
11.1.3 Increase in Awareness Levels of Disease Progression and Etiology 96
11.2 Market Restraints 96
11.2.1 Entry of Generics Pose a Serious Problem for Primary Manufacturers 96
11.2.2 Presence of Serious Side Effects for Certain Classes of Therapeutic drugs 96
12 Global Dermatology Therapeutics Market : Key Market Trends 97
13 Global Dermatology Therapeutics Market: Competitive Landscape 98
13.1 Overview 98
13.2 Market Share Analysis 98
13.3 Competitive Profiling 98
13.3.1 GlaxoSmithKline plc (GSK) 98
13.3.2 Johnson & Johnson 100
13.3.3 Bayer AG 102
13.3.4 Merck & Co., Inc 103
13.3.5 Novartis AG 105
13.3.6 Sanofi-Aventis 106
13.3.7 LEO Pharma A/S 107
13.3.8 F. Hoffmann-La Roche Ltd 108
13.3.9 L'Oreal 109
13.3.10 Galderma S.A. 109
13.3.11 Nestle S.A. 110
14 Dermatology Thereapeutics Market: Pipeline Analysis 112
14.1 Pipeline I 113
14.2 Pipeline II 118
14.3 Pipeline III 133
14.4 Promising Drugs under Clinical Development 143
14.4.1 Voclosporin (LX211, LUVENIQ, ISA-247) 143
14.4.2 ABT-874 (J-695, Briakinumab) 143
14.4.3 CF-101 144
14.4.4 Orencia (abatacept, CTLA4-Ig, BMS-188667) 144
14.4.5 Cimzia (CDP870 certolizumab pegol) 144
14.4.6 Apremilast (CC10004, ACR20) 144
14.4.7 INCB18424 144
14.4.8 PH-10 144
14.4.9 Hivenyl 144
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 4/11

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
14.4.10 TF002 145
15 Global Dermatology Therapeutics Market: M&A Landscape 146
15.1 Mergers and Acquisitions 146
15.1.1 Overview 146
15.2 Licensing Agreements 146
15.2.1 Overview 146
15.2.2 Drug Discovery & Preclinical 149
15.2.3 Phase I 150
15.2.4 Phase II 152
15.2.5 Phase III 153
15.2.6 Approved Stage 154
16 Global Dermatology Therapeutics Market : Appendix 159
16.1 Market Definitions 159
16.2 Abbreviations 159
16.3 Research Methodology 160
16.3.1 Coverage 160
16.3.2 Secondary Research 161
16.3.3 Primary Research 161
16.3.4 Forecasts 162
16.3.5 Expert Panel Validation 164
16.4 Contact Us 165
16.5 Disclaimer 165
1.1 List of Tables
Table 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 13
Table 2: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 13
Table 3: Dermatology Therapeutics Market, Global, Diseased Population, 2001-2009 14
Table 4: Dermatology Therapeutics Market, Global, Diseased Population, 2009-2016 14
Table 5: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 15
Table 6: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 15
Table 7: Dermatology Therapeutics Market, Global, Diagnosis Population, 2001-2009 16
Table 8: Dermatology Therapeutics Market, Global, Diagnosis Population, 2009-2016 16
Table 9: Dermatology Therapeutics Market, Global, Prescription Population, 2001-2009 17
Table 10: Dermatology Therapeutics Market, Global, Prescription Population, 2009-2016 17
Table 11: Dermatology Therapeutics Market, Global, Usage Patterns, 2001-2009 18
Table 12: Dermatology Therapeutics Market, Global, Usage Patterns, 2009-2016 19
Table 13: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2001-2009 20
Table 14: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2009-2016 20
Table 15: Dermatology Therapeutics Market, The U.S, Diseased Population, 2001-2009 21
Table 16: Dermatology Therapeutics Market, The U.S, Diseased Population, 2009-2016 21
Table 17: Dermatology Therapeutics Market, The US, Treatment Seeking Population, 2001-2009 22
Table 18: Dermatology Therapeutics Market, The US, Treatment Seeking Population, 2009-2016 22
Table 19: Dermatology Therapeutics Market, The US, Diagnosis Population, 2001-2009 23
Table 20: Dermatology Therapeutics Market, The US, Diagnosis Population, 2009-2016 23
Table 21: Dermatology Therapeutics Market, The US, Prescription Population, 2001-2009 24
Table 22: Dermatology Therapeutics Market, The US, Prescription Population, 2009-2016 24
Table 23: Dermatology Therapeutics Market, The US, Usage Patterns, 2001-2009 25
Table 24: Dermatology Therapeutics Market, The US, Usage Patterns, 2009-2016 26
Table 25: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2001-2009 27
Table 26: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2009-2016 27
Table 27: Dermatology Therapeutics Market, Europe, Diseased Population, 2001-2009 28
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 5/11

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 28: Dermatology Therapeutics Market, Europe, Diseased Population, 2009-2016 28
Table 29: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2001-2009 29
Table 30: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2009-2016 29
Table 31: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2001-2009 30
Table 32: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2009-2016 30
Table 33: Dermatology Therapeutics Market, Europe, Prescription Population, 2001-2009 31
Table 34: Dermatology Therapeutics Market, Europe, Prescription Population, 2009-2016 31
Table 35: Dermatology Therapeutics Market, Europe, Usage Patterns, 2001-2009 32
Table 36: Dermatology Therapeutics Market, Europe, Usage Patterns, 2009-2016 33
Table 37: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2001-2009 34
Table 38: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2009-2016 34
Table 39: Dermatology Therapeutics Market, Japan, Diseased Population, 2001-2009 35
Table 40: Dermatology Therapeutics Market, Japan, Diseased Population, 2009-2016 35
Table 41: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2001-2009 36
Table 42: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2009-2016 36
Table 43: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2001-2009 37
Table 44: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2009-2016 37
Table 45: Dermatology Therapeutics Market, Japan, Prescription Population, 2001-2009 38
Table 46: Dermatology Therapeutics Market, Japan, Prescription Population, 2009-2016 38
Table 47: Dermatology Therapeutics Market, Japan, Usage Patterns, 2001-2009 39
Table 48: Dermatology Therapeutics Market, Japan, Usage Patterns, 2009-2016 40
Table 49: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 42
Table 50: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 42
Table 51: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2009 43
Table 52: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($) 2009-2016 43
Table 53: Psoriasis Therapeutics Market, Global, Diseased Population, 2001-2009 44
Table 54: Psoriasis Therapeutics Market, Global, Diseased Population, 2009-2016 45
Table 55: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 45
Table 56: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 46
Table 57: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2001-2009 47
Table 58: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2009-2016 47
Table 59: Psoriasis Therapeutics Market, Global, Prescription Population, 2001-2009 48
Table 60: Psoriasis Therapeutics Market, Global, Prescription Population, 2009-2016 48
Table 61: Psoriasis Therapeutics Market, Global, Usage Patterns, 2001-2009 49
Table 62: Psoriasis Therapeutics Market, Global, Usage Patterns, 2009-2016 49
Table 63: Psoriasis Therapeutics ' Phase III Clinical Pipeline, 2009 53
Table 64: Psoriasis Therapeutics ' Phase II Clinical Pipeline, 2009 54
Table 65: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 58
Table 66: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 58
Table 67: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2001-2009 59
Table 68: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2009-2016 59
Table 69: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2001-2009 60
Table 70: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2009-2016 60
Table 71: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 61
Table 72: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 61
Table 73: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2001-2009 62
Table 74: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2009-2016 62
Table 75: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2001-2009 63
Table 76: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2009-2016 63
Table 77: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2001-2009 64
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 6/11

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 78: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2009-2016 65
Table 79: Atopic Dermatitis Therapeutics ' Phase III Clinical Pipeline, 2010 67
Table 80: Atopic Dermatitis Therapeutics ' Phase II Clinical Pipeline, 2010 68
Table 81: Atopic Dermatitis Therapeutics ' Phase I Clinical Pipeline, 2010 69
Table 82: Atopic Dermatitis Therapeutics ' Pre-Clinical Pipeline, 2010 69
Table 83: Atopic Dermatitis Therapeutics ' Discovery Pipeline, 2010 70
Table 84: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 72
Table 85: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 72
Table 86: Acne Therapeutics Market, Global, Diseased Population, 2001-2009 73
Table 87: Acne Therapeutics Market, Global, Diseased Population, 2009-2016 73
Table 88: Acne Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 74
Table 89: Acne Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 74
Table 90: Acne Therapeutics Market, Global, Diagnosis Population, 2001-2009 75
Table 91: Acne Therapeutics Market, Global, Diagnosis Population, 2009-2016 75
Table 92: Acne Therapeutics Market, Global, Prescription Population, 2001-2009 76
Table 93: Acne Therapeutics Market, Global, Prescription Population, 2009-2016 76
Table 94: Acne Therapeutics Market, Global, Usage Patterns, 2001-2009 77
Table 95: Acne Therapeutics Market, Global, Usage Patterns, 2009-2016 78
Table 96: Acne Therapeutics Market , Clinical Pipeline , 2009 79
Table 97: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2009 84
Table 98: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2009-2016 85
Table 99: Rosacea Therapeutics Market, Global, Average Cost of Therapy, ($) 2001-2009 85
Table 100: Rosacea Therapeutics Market, Global, Average Cost of Therapy ($), 2009-2016 85
Table 101: Rosacea Therapeutics Market, Global, Diseased Population, 2001-2009 87
Table 102: Rosacea Therapeutics Market, Global, Diseased Population, 2009-2016 87
Table 103: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 88
Table 104: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 88
Table 105: Rosacea Therapeutics Market, Global, Diagnosis Population, 2001-2009 89
Table 106: Rosacea Therapeutics Market, Global, Diagnosis Population, 2009-2016 89
Table 107: Rosacea Therapeutics Market, Global, Prescription Population, 2001-2009 90
Table 108: Rosacea Therapeutics Market, Global, Prescription Population, 2009-2016 90
Table 109: Rosacea Therapeutics Market, Global, Usage Patterns, 2001-2009 91
Table 110: Rosacea Therapeutics Market, Global, Usage Patterns, 2009-2016 91
Table 111: Rosacea Therapeutics ' Clinical Pipeline, 2009 93
Table 112: Dermatology Therapeutics Market, Global, Market Drivers, 2008 95
Table 113: Dermatology Therapeutics Market, Global, Market Restraints, 2008 96
Table 114: Dermatology Therapeutics Market, Global, Phase I Pipeline, 2009 113
Table 115: Dermatology Therapeutics Market, Global, Phase II Pipeline, 2009 118
Table 116: Dermatology Therapeutics Market, Global, Phase III Pipeline, 2009 133
Table 117: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Discovery and Preclinical Stages,
2002-2009 149
Table 118: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase I Stage, 1998-2009 150
Table 119: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase II Stages, 1998-2008 152
Table 120: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Phase III Stages, 2002-2008 153
Table 121: Dermatology Therapeutics Market, Global, Licensing Agreements for Drugs in the Approved Stages, 2001-2009 154
1.2 List of Figures
Figure 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 13
Figure 2: Dermatology Therapeutics Market, Global, Diseased Population, 2001-2016 14
Figure 3: Dermatology Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 15
Figure 4: Dermatology Therapeutics Market, Global, Diagnosis Population, 2001-2016 16
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 7/11

8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 5: Dermatology Therapeutics Market, Global, Prescription Population, 2001-2016 17
Figure 6: Dermatology Therapeutics Market, Global, Usage Patterns, 2001-2016 18
Figure 7: Dermatology Therapeutics Market, Global, Geographical Distribution of Revenues ($m), 2001-2016 19
Figure 8: Dermatology Therapeutics Market, The US, Revenue Forecasts ($m), 2001-2016 20
Figure 9: Dermatology Therapeutics Market, The US, Diseased Population, 2001-2016 21
Figure 10: Dermatology Therapeutics Market, The U.S, Treatment Seeking Population, 2001-2016 22
Figure 11: Dermatology Therapeutics Market, The US, Diagnosis Population, 2001-2016 23
Figure 12: Dermatology Therapeutics Market, The US, Prescription Population, 2001-2016 24
Figure 13: Dermatology Therapeutics Market, The US, Usage Patterns, 2001-2016 25
Figure 14: Dermatology Therapeutics Market, Europe, Revenue Forecasts ($m), 2001-2016 27
Figure 15: Dermatology Therapeutics Market, Europe, Diseased Population, 2001-2016 28
Figure 16: Dermatology Therapeutics Market, Europe, Treatment Seeking Population, 2001-2016 29
Figure 17: Dermatology Therapeutics Market, Europe, Diagnosis Population, 2001-2016 30
Figure 18: Dermatology Therapeutics Market, Europe, Prescription Population, 2001-2016 31
Figure 19: Dermatology Therapeutics Market, Europe, Usage Patterns, 2001-2016 32
Figure 20: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($m), 2001-2016 34
Figure 21: Dermatology Therapeutics Market, Japan, Diseased Population, 2001-2016 35
Figure 22: Dermatology Therapeutics Market, Japan, Treatment Seeking Population, 2001-2016 36
Figure 23: Dermatology Therapeutics Market, Japan, Diagnosis Population, 2001-2016 37
Figure 24: Dermatology Therapeutics Market, Japan, Prescription Population, 2001-2016 38
Figure 25: Dermatology Therapeutics Market, Japan, Usage Patterns, 2001-2016 39
Figure 26: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 42
Figure 27: Psoriasis Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2016 43
Figure 28: Psoriasis Therapeutics Market, Global, Diseased Population, 2001-2016 44
Figure 29: Psoriasis Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 45
Figure 30: Psoriasis Therapeutics Market, Global, Diagnosis Population, 2001-2016 46
Figure 31: Psoriasis Therapeutics Market, Global, Prescription Population, 2001-2016 47
Figure 32: Psoriasis Therapeutics Market, Global, Usage Patterns, 2001-2016 49
Figure 33: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 57
Figure 34: Atopic Dermatitis Therapeutics Market, Global, Average Cost of Therapy, 2001-2016 59
Figure 35: Atopic Dermatitis Therapeutics Market, Global, Diseased Population, 2001-2016 60
Figure 36: Atopic Dermatitis Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 61
Figure 37: Atopic Dermatitis Therapeutics Market, Global, Diagnosis Population, 2001-2016 62
Figure 38: Atopic Dermatitis Therapeutics Market, Global, Prescription Population, 2001-2016 63
Figure 39: Atopic Dermatitis Therapeutics Market, Global, Usage Patterns, 2001-2016 64
Figure 40: Acne Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 71
Figure 41: Acne Therapeutics Market, Global, Diseased Population, 2001-2016 73
Figure 42: Acne Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 74
Figure 43: Acne Therapeutics Market, Global, Diagnosis Population, 2001-2016 75
Figure 44: Acne Therapeutics Market, Global, Prescription Population, 2001-2016 76
Figure 45: Acne Therapeutics Market, Global, Usage Patterns, 2001-2016 77
Figure 46: Acne Therapeutics Market, Clinical Pipeline by Phase, 2009 78
Figure 47: Rosacea Therapeutics Market, Global, Revenue Forecasts ($m), 2001-2016 84
Figure 48: Rosacea Therapeutics Market, Global, Average Cost of Therapy ($), 2001-2016 85
Figure 49: Rosacea Therapeutics Market, Global, Diseased Population, 2001-2016 86
Figure 50: Rosacea Therapeutics Market, Global, Treatment Seeking Population, 2001-2016 87
Figure 51: Rosacea Therapeutics Market, Global, Diagnosis Population, 2001-2016 88
Figure 52: Rosacea Therapeutics Market, Global, Prescription Population, 2001-2016 89
Figure 53: Rosacea Therapeutics Market, Global, Usage Patterns, 2001-2016 90
Figure 54: Rosacea Therapeutics ' Clinical Pipeline by Drug Development Phase, 2009 92
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 8/11

9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 55: Dermatology Therapeutics Market, Global, Market Indicators, 2009 95
Figure 56: Dermatology Therapeutics Market, Global, Key Market Events, 2008-2015 97
Figure 57: Dermatology Therapeutics Market, Global, Leading Companies, 2009 98
Figure 58: Dermatology Therapeutics Market, Global, Pipeline by Phase, 2009 112
Figure 59: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Indication, 2009 147
Figure 60: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Clinical Trial Phase, 2009 147
Figure 61: Dermatology Therapeutics Market, Global, Licensing Agreements Split by Geography, 2009 148
Figure 62: GBI Research Methodology, 2010 161
Figure 63: GBI Research Market Forecasting Methodology, 2010 164
Companies mentioned
GlaxoSmithKline plc (GSK)
Johnson & Johnson
Bayer AG
Merck & Co., Inc
Novartis AG
Sanofi-Aventis
LEO Pharma A/S
F. Hoffmann-La Roche Ltd
L'Oreal
Galderma S.A
Nestle S.A.
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 9/11

10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate t
o Drive Revenues
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 3 500.00 Quantity: _____
Site License--USD 7 000.00 Quantity: _____
Corporate License--USD 10 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 10/11

11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues Page 11/11